HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tuberactinomycin

Networked: 8 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Viomycin: 111
      - Enviomycin: 19
        tuberactinomycin: 8
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Viomycin: 111
      - Enviomycin: 19
        tuberactinomycin: 8

Experts

1.	Thomas, Michael G: 2 articles (07/2007 - 09/2003)
2.	Borg, Anneli: 1 article (01/2016)
3.	Ehrenberg, Måns: 1 article (01/2016)
4.	Holm, Mikael: 1 article (01/2016)
5.	Sanyal, Suparna: 1 article (01/2016)
6.	Akbergenov, Rashid: 1 article (10/2011)
7.	Böttger, Erik C: 1 article (10/2011)
8.	Duscha, Stefan: 1 article (10/2011)
9.	Matt, Tanja: 1 article (10/2011)
10.	Meyer, Martin: 1 article (10/2011)

Related Diseases

1.	Ototoxicity 10/01/2011 - "We identified rRNA residues in h44 as the main determinants of phylogenetic selectivity, predict compensatory evolution to impact future resistance development, and propose mechanisms involved in tuberactinomycin ototoxicity, which may enable the development of improved, less-toxic derivatives."
2.	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/01/2003 - "The tuberactinomycin antibiotics are essential components in the drug arsenal against Mycobacterium tuberculosis infections and are specifically used for the treatment of multidrug-resistant tuberculosis. " 01/26/2016 - "Viomycin is a tuberactinomycin antibiotic essential for treating multidrug-resistant tuberculosis. " 03/01/2010 - "Viomycin and capreomycin belong to the tuberactinomycin family of antibiotics, which are among the most effective antibiotics against multidrug-resistant tuberculosis. " 07/01/2007 - "Capreomycin (CMN) belongs to the tuberactinomycin family of nonribosomal peptide antibiotics that are essential components of the drug arsenal for the treatment of multidrug-resistant tuberculosis. "
3.	Tuberculosis (Tuberculoses) 01/01/2022 - "Beginning with the identification of viomycin in the early 1950s, this mini-review briefly describes tuberactinomycin structures and biosynthesis, as well as their past and present application in the treatment of tuberculosis caused by infection with Mycobacterium tuberculosis. " 09/01/2003 - "The tuberactinomycin antibiotics are essential components in the drug arsenal against Mycobacterium tuberculosis infections and are specifically used for the treatment of multidrug-resistant tuberculosis. " 11/16/2010 - "Viomycin belongs to the tuberactinomycin family of antibiotics against tuberculosis. "
4.	Pulmonary Tuberculosis 05/01/1992 - "A total of 114 strains of Mycobacterium tuberculosis isolated from sputum samples of 114 patients of pulmonary tuberculosis in south India, were coded and tested for their in vitro susceptibility to tuberactinomycin (Tum) incorporated in Lowenstein-Jensen (LJ) medium. "
5.	Infections 01/01/2022 - "Beginning with the identification of viomycin in the early 1950s, this mini-review briefly describes tuberactinomycin structures and biosynthesis, as well as their past and present application in the treatment of tuberculosis caused by infection with Mycobacterium tuberculosis. "

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	Viomycin (Viocin)
3.	Capreomycin (Capastat)
4.	Peptides (Polypeptides)